MyFiziq (ASX:MYQ) share price at record high. Here's why.

The MyFiziq share price reached a 52-week high today following the release of a new binding term sheet. Has this created a buying opportunity?

| More on:
Hands grabbing for high rung on a ladder pointing to the sky

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The MyFiziq Ltd (ASX: MYQ) share price has been on the move today following the release of a new binding term sheet. During intra-day trade, the MyFiziq share price reached a record high of $1.50 before falling down to $1.25. At the time of writing, the MyFiziq share price has settled at $1.34, up 1.5%.

Let's take a look to what MyFiziq announced today.

New agreement

MyFiziq advised it has signed a significant binding term sheet with Nexus Vita Pte Ltd, a Singapore-based health monitoring and management tech company.

In detail, Nexus has developed a system that bridges medical health and wellness management of an individual. The application tracks and manages medical and health records onto an easy-to-access digital platform, which can be shared with a medical professional. Nexus-Vita's aim is to improve lifetime health and reduce the need for medical procedures, saving costs and resources to user and government health systems.

Under the agreement, both companies will add MyFiziq's CompleteScan platform into all of Nexus-Vita's products. The partnership will begin with the integrated rollout of Nexus-Vita's pre-emptive health app. It is expected to be available to market by January 2021.

The conditions stipulate Nexus-Vita will deliver a minimum of 100,000 active users to the platform within the first 12 months of launch. This will be backed by a minimum revenue guarantee of US$3,588,00 per annum paid to MyFiziq.

As Nexus-Vita operates mostly in the greater Asia region, price sensitivity was a key driver to achieving its marketing strategy. As a result, Nexus-Vita will lower the per user month price of US$5.49 to US$2.99, reflecting a 46% discount.

What did management say?

MyFiziq CEO Vlado Bosanac said the transaction was a turning point in MyFiziq's pathway to revenue and profit. He said:

Nexus-Vita is taking advantage of the global need for digital health engagement, which has seen a significant increase with individuals reluctant to attend medical facilities, and the compounding strain being experienced by the healthcare system worldwide as a result of the current pandemic.

Nexus-Vita has identified, developed, and entered the market with a dynamic and well-resourced offering. I am pleased to be working with Jeff and the Nexus-Vita team to provide the CompleteScan platform capabilities to their unique intervention, monitoring and pre-emptive health solution."

Mr Bosanac mentioned the identifiable market opportunities that had arisen due to COVID-19, adding:

With the COVID-19 pandemic, the world has experienced a surge in mHealth, telehealth, virtual care and preventative health investment. Nexus-Vita's user monitoring and engagement-based platform is in good company with recent activities in the digital health, telehealth, and medical sectors, which saw Teledoc, acquire Livongo for USD$18.5 billion.

Nexus-Vita is targeting both intervention and early identification of addressable disease prior to current preventative healthcare solutions, which is unique and innovative in this much-needed and accepted market segment.

MyFiziq share price performance

The positive announcement is good news for investors and will likely further fuel the meteoric MyFiziq share price rise. Since the start of the year, the MyFiziq share price has jumped more than 400% to reach its all-time high of $1.49 today. A market capitalisation of $155 million, the company has a huge runway ahead should it exceed market expectations.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Green stock market graph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was one for the history books today.

Read more »

Person holding a blue chip.
Blue Chip Shares

4 ASX 200 blue-chip shares to hold but not buy: experts

These blue-chips are worth holding if you already own them, but are too expensive for new investors to buy.

Read more »

A bricklayer peeps over the top of a brick wall he is laying with a level measuring tool on top.
Broker Notes

Are Brickworks shares a buy, hold or sell ahead of earnings season?

Brokers have been weighing property gains, US headwinds, and merger impacts to form a view.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Record Highs

The ASX 200 just hit a new record high. Here's why.

The prospect of lower interest rates is pushing the market into new territory.

Read more »

Three guys in shirts and ties give the thumbs down.
Share Fallers

Why Appen, Emerald Resources, IGO, and Strike Energy shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Boss Energy, DroneShield, Pilbara Minerals, and Polynovo shares are charging higher today

These shares are having a good time on hump day. But why?

Read more »

Interest rate written in white with an increasing pile of coins.
Share Market News

ASX 200 lifts off as inflation data spurs hope for RBA interest rate cuts

ASX 200 investors are celebrating the latest inflation reading. But why?

Read more »